Tango Therapeutics Inc (TNGX)
7.61
+0.02
(+0.26%)
USD |
NASDAQ |
May 03, 16:00
7.615
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Cash from Investing (TTM): 41.43M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 41.43M |
September 30, 2023 | -5.031M |
June 30, 2023 | 66.86M |
March 31, 2023 | 69.67M |
December 31, 2022 | 26.40M |
Date | Value |
---|---|
September 30, 2022 | -6.203M |
June 30, 2022 | -173.64M |
March 31, 2022 | -215.76M |
December 31, 2021 | -183.43M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-215.76M
Minimum
Mar 2022
69.67M
Maximum
Mar 2023
-42.19M
Average
-5.031M
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
Aquestive Therapeutics Inc | -0.995M |
2seventy bio Inc | 43.86M |
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |